Abstract
A group of 78 patients with severe hypercholesterolemia (x = 464 mg/dl) and symptoms of vascular disease of the heart, the extremities, or the brain, started a beta-pyridylcarbinol treatment with an average daily dosage of 1.2 g in 1964. In 1976 we could re-examine 12 patients, still on the same therapy. No myocardial infarction has occurred in this group since 1973, only 2 patients have had more attacks of angina pectoris than 1964. In contrast patients discontinuing therapy or replacing beta-pyridylcarbinol by other hypolipidemic drugs had a higher mortality.
Original language | English |
---|---|
Pages (from-to) | 611-615 |
Number of pages | 5 |
Journal | Atherosclerosis |
Volume | 26 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1977 |
Externally published | Yes |
Keywords
- Beta pyridylcarbinol
- Hypercholesterolemia
- Long-term treatment
- Serum cholesterol levels